BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 15084522)

  • 1. Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass.
    Jones SW; Hill RJ; Krasney PA; O'Conner B; Peirce N; Greenhaff PL
    FASEB J; 2004 Jun; 18(9):1025-7. PubMed ID: 15084522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle disuse atrophy is not accompanied by changes in skeletal muscle satellite cell content.
    Snijders T; Wall BT; Dirks ML; Senden JM; Hartgens F; Dolmans J; Losen M; Verdijk LB; van Loon LJ
    Clin Sci (Lond); 2014 Apr; 126(8):557-66. PubMed ID: 24215591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging affects the transcriptional regulation of human skeletal muscle disuse atrophy.
    Suetta C; Frandsen U; Jensen L; Jensen MM; Jespersen JG; Hvid LG; Bayer M; Petersson SJ; Schrøder HD; Andersen JL; Heinemeier KM; Aagaard P; Schjerling P; Kjaer M
    PLoS One; 2012; 7(12):e51238. PubMed ID: 23284670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disuse atrophy of human skeletal muscle: cell signaling and potential interventions.
    Urso ML
    Med Sci Sports Exerc; 2009 Oct; 41(10):1860-8. PubMed ID: 19727028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular physiology of human limb immobilization and rehabilitation.
    Greenhaff PL
    Exerc Sport Sci Rev; 2006 Oct; 34(4):159-63. PubMed ID: 17031253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle atrophy: disease-induced mechanisms may mask disuse atrophy.
    Malavaki CJ; Sakkas GK; Mitrou GI; Kalyva A; Stefanidis I; Myburgh KH; Karatzaferi C
    J Muscle Res Cell Motil; 2015 Dec; 36(6):405-21. PubMed ID: 26728748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy.
    Gilson H; Schakman O; Combaret L; Lause P; Grobet L; Attaix D; Ketelslegers JM; Thissen JP
    Endocrinology; 2007 Jan; 148(1):452-60. PubMed ID: 17038559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy.
    Reardon KA; Davis J; Kapsa RM; Choong P; Byrne E
    Muscle Nerve; 2001 Jul; 24(7):893-9. PubMed ID: 11410916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined isometric, concentric, and eccentric resistance exercise prevents unloading-induced muscle atrophy in rats.
    Adams GR; Haddad F; Bodell PW; Tran PD; Baldwin KM
    J Appl Physiol (1985); 2007 Nov; 103(5):1644-54. PubMed ID: 17872405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of skeletal muscle atrophy.
    Jackman RW; Kandarian SC
    Am J Physiol Cell Physiol; 2004 Oct; 287(4):C834-43. PubMed ID: 15355854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic and epigenetic regulation of disuse atrophy and the return to activity in skeletal muscle.
    Fisher AG; Seaborne RA; Hughes TM; Gutteridge A; Stewart C; Coulson JM; Sharples AP; Jarvis JC
    FASEB J; 2017 Dec; 31(12):5268-5282. PubMed ID: 28821632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immobilization-induced activation of key proteolytic systems in skeletal muscles is prevented by a mitochondria-targeted antioxidant.
    Talbert EE; Smuder AJ; Min K; Kwon OS; Szeto HH; Powers SK
    J Appl Physiol (1985); 2013 Aug; 115(4):529-38. PubMed ID: 23766499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasticity and function of human skeletal muscle in relation to disuse and rehabilitation: Influence of ageing and surgery.
    Suetta C
    Dan Med J; 2017 Aug; 64(8):. PubMed ID: 28869034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight.
    Lalani R; Bhasin S; Byhower F; Tarnuzzer R; Grant M; Shen R; Asa S; Ezzat S; Gonzalez-Cadavid NF
    J Endocrinol; 2000 Dec; 167(3):417-28. PubMed ID: 11115768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and molecular events controlling skeletal muscle mass in response to altered use.
    Favier FB; Benoit H; Freyssenet D
    Pflugers Arch; 2008 Jun; 456(3):587-600. PubMed ID: 18193272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantial skeletal muscle loss occurs during only 5 days of disuse.
    Wall BT; Dirks ML; Snijders T; Senden JM; Dolmans J; van Loon LJ
    Acta Physiol (Oxf); 2014 Mar; 210(3):600-11. PubMed ID: 24168489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle atrophy during short-term disuse: implications for age-related sarcopenia.
    Wall BT; Dirks ML; van Loon LJ
    Ageing Res Rev; 2013 Sep; 12(4):898-906. PubMed ID: 23948422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms regulating muscle mass during disuse atrophy and rehabilitation in humans.
    Marimuthu K; Murton AJ; Greenhaff PL
    J Appl Physiol (1985); 2011 Feb; 110(2):555-60. PubMed ID: 21030670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal muscle immobilisation-induced atrophy: mechanistic insights from human studies.
    Deane CS; Piasecki M; Atherton PJ
    Clin Sci (Lond); 2024 Jun; 138(12):741-756. PubMed ID: 38895777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance exercise and the mechanisms of muscle mass regulation in humans: acute effects on muscle protein turnover and the gaps in our understanding of chronic resistance exercise training adaptation.
    Murton AJ; Greenhaff PL
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2209-14. PubMed ID: 23872221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.